fda warning letters glp-1 compounding october 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading FDA warning letters target marketers

Obese patients, have been reported to produce more SCFAs in their intestines (310), but indeed meaningful diet-induced shifts in SCFA production fluxes have proven not sufficient to modulate peripheral levels of GLP-1 and PYY (311)

10.1186/s13052014-00924 6

whole grains for carbs) can maximize the benefit

Im receiving a lot of enquiries about peptides from my patients, particularly BPC-157 and TB-500, which are booming in sports injury

Whether you prefer a once-weekly injection or want to discuss upcoming oral GLP-1 options, were here to help you find a safe, evidence-based solution

References and Storage Sources Peptide stability guidance is consistent on the main principle: dry peptide powder is more stable than peptide solution, and reconstituted peptides require shorter, colder, cleaner handling